Delivery Order SPE2DB22D2206-SPE2DB25FFJ67

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,392,825 units of the pharmaceutical product Flucytosine 250 mg Capsules. The contract has a firm fixed price of $17,628.71 and a completion date of August 9, 2024. The contract is not set aside for a specific business type. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
This federal contract award, valued at $11,630.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLUCYTOSINE 500 MG CAPSULE UD 30S, a pharmaceutical product. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of February 6, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug...
This is a $23,317.20 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,560,224 capsules of the pharmaceutical drug flucytosine 500 mg with a period of performance through May 10, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product: FLUCYTOSINE 250 MG CAPSULE UD 30S. The delivery order has a potential value of $12,937.31 and a completion date of December 20, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceuticals, medical...
This federal contract award, with the ID SPE2DB20D3103|SPE2DB25FM9J5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567466690 - FLUCYTOSINE 500 MG CAPSULE UD 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $46,634.40 and a period of performance through March 6, 2025. The contract does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,464.10 firm fixed price delivery order is for the supply of Fluconazole 150 mg tablets to support federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award, valued at $3,051.31, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FLUOROURACIL 5% CREAM 40GM, a specialty pharmaceutical product, to support military and federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $2,336.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of FLUOROURACIL 5% CREAM 40GM, a medical product used for various healthcare applications. The contract has an ultimate completion date of November 18, 2024 and is structured as a Firm Fixed Price Delivery Order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,951.80 firm fixed-price delivery order is for the supply of FLUOROURACIL 5% CREAM 40GM, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,264.44 firm fixed-price contract is for the supply of 4,565,441,631 units of the generic pharmaceutical Fluconazole 150 mg tablets. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide essential medical commodities, including...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFJ67
    Delivery Order

This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,772.40, is for the delivery of the drug flucytosine 500 mg capsules, a prescription medication used to treat fungal infections. The contract is a firm fixed-price delivery order with a completion date of February 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 5/2/25, 9:42 AM